Physician Professionalism and Changes in Physician-Industry Relationships From 2004 to 2009

被引:101
作者
Campbell, Eric G. [1 ,3 ]
Rao, Sowmya R. [1 ,3 ]
DesRoches, Catherine M. [1 ,3 ]
Iezzoni, Lisa I. [1 ,3 ]
Vogeli, Christine [1 ,3 ]
Bolcic-Jankovic, Dragana [2 ]
Miralles, Paola D. [1 ]
机构
[1] Univ Massachusetts, Mongan Inst Hlth Policy, Massachusetts Gen Hosp, Boston, MA 02125 USA
[2] Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
CONFLICTS-OF-INTEREST; HEALTH-CARE; PROPOSAL; COST; US;
D O I
10.1001/archinternmed.2010.383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One tenet of medical professionalism is managing conflicts of interest related to physician-industry relationships (PIRs). Since 2004 much has been done at the institutional, state, and national levels to limit PIRs. This study estimates the nature, extent, consequences, and changes in PIRs nationally. Methods: We performed a national survey of a stratified random sample of 2938 primary care physicians (internal medicine, family practice, and pediatrics) and specialists (cardiology, general surgery, psychiatry, and anesthesiology). A total of 1891 physicians completed the survey, yielding an overall response rate of 64.4%. The main outcome measure was prevalence of several types of PIRs and comparison with PIRs in 2004. Results: Overall, 83.8% of all respondents reported some type of relationship with industry during the previous year. Approximately two-thirds (63.8%) received drug samples, 70.6% food and beverages, 18.3% reimbursements, and 14.1% payments for professional services. Since 2004 the percentage of each of these benefits has decreased significantly. Higher rates of PIRs are significantly and inversely associated with low levels of Medicare spending. Conclusion: Among a random sample of physicians, the prevalence of self-reported PIRs in 2009 was 83.8%, which was lower than in 2004.
引用
收藏
页码:1820 / 1826
页数:7
相关论文
共 22 条
  • [1] *ABIM FDN, MED PROF NEW MILL PH
  • [2] Abramson J., 2004, Overdosed America, the broken promise of American medicine
  • [3] Angell M., 2005, TRUTH DRUG COMPANIES
  • [4] [Anonymous], DIV PHYS WORKF FACTS
  • [5] Association of American Medical Colleges, 2014, DIV PHYS WORKF FACTS
  • [6] Avorn Jerry., 2004, Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs
  • [7] Health industry practices that create conflicts of interest - A policy proposal for academic medical centers
    Brennan, TA
    Rothman, DJ
    Blank, L
    Blumenthal, D
    Chimonas, SC
    Cohen, JJ
    Goldman, J
    Kassirer, JP
    Kimball, H
    Naughton, J
    Smelser, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (04): : 429 - 433
  • [8] A national survey of physician-industry relationships
    Campbell, Eric G.
    Gruen, Russell L.
    Mountford, James
    Miller, Lawrence G.
    Cleary, Paul D.
    Blumenthal, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17) : 1742 - 1750
  • [9] Show Us the Money: Lessons in Transparency from State Pharmaceutical Marketing Disclosure Laws
    Chimonas, Susan
    Rozario, Natassia M.
    Rothman, David J.
    [J]. HEALTH SERVICES RESEARCH, 2010, 45 (01) : 98 - 114
  • [10] No More Free Drug Samples?
    Chimonas, Susan
    Kassirer, Jerome P.
    [J]. PLOS MEDICINE, 2009, 6 (05):